Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as TIL-based therapies.

Driven by a promising development pipeline and encouraging clinical trial results, the TIL-based therapy market is likely to carve out a significant share of the cancer immunotherapy market. The financial opportunity within the TIL-based therapy market has been analyzed across the following segments:

 

  • Target Indication(s)
  • Melanoma
  • Head and Neck Carcinoma
  • Chronic Lymphocytic Leukemia
  • Sarcoma
  • Hepatocellular Carcinoma
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Cervical Carcinoma

 

  • Key Geographical Regions 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World 

 

The Global TIL Therapy Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:

  • Cellectis
  • Cellular Biomedicine Group
  • Iovance Biotherapeutics
  • Lytix Biopharma
  • Phio Pharmaceuticals

 

Table of Contents

 

  1. Preface      
  2. Executive Summary
  3. Introduction
  4. TIL-based Therapies: Market Landscape
  5. Clinical Trial Analysis
  6. Key Opinion Leaders
  7. TIL-based Therapy Profiles
  8. Partnerships And Collaborations
  9. Funding And Investment Analysis
  10. Patent Analysis
  11. Case Study: Cell Therapy Manufacturing
  12. Cost Price Analysis
  13. Market Forecast and Opportunity Analysis
  14. Company Profiles
  15. Concluding Remarks
  16. Executive Insights
  17. Appendix I: Tabulated Data
  18. Appendix II: List of Companies and Organizations

 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/til-therapies-market.html

 

You may also be interested in the following titles:

Decentralized Clinical Trials / Virtual Clinical Trials Market 

Global Antibiotics Market

 

                 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

Contact:

Ben Johnson

+1 (415) 800 3415

[email protected]